You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 13 Next »

Project Scope

Impact assessment of the estimands framework and recommendations/best practices (where applicable) for implementing the framework in the following areas:

  • Data Collect Design/CDASH
  • SDTM
  • ADaM (including handling of intercurrent events, missing data imputation) – Analysis Displays
  • cSDRG and ADRG

Development of new standards is not in scope, and any impact findings that may necessitate new standard development will be shared with CDISC for their consideration. Examples may be created on how to implement the framework by using permitted extensions to the existing data standards.

Project LeadsEmail
Chris Price

Katie Warren (PHUSE Project Assistant)

Objectives & DeliverablesTimelines

Kick off

Q1 2022

Review current company practices 

Q1 2022

Develop conference abstract 

Q2 2022

Draft paper

Q3 2022 

Conference slides 

Q4 2022

Final paper for public review

Q4 2022

Final paper published

Q1 2023


Project approved Q1 2022
Project MembersOrganisation 
Cedric Davister Merck
Rama Empati AstraZeneca
Bess LeroyCDISC
Lisa Lin FDA
Santosh K Lingala Gilead 
Kim Musgrave Amgen 
Yongming QuEli Lilly and Company 
John Scott FDA
Liping SunFDA
Robin White Eli Lilly and Company 
Steve Wilson FDA
  • No labels